|
|
Targeting Surface Nucleolin Induces Autophagy-dependent Cell Ceath in Pancreatic
Cancer via AMPK Activation
|
author: |
Xu C, Wang Y, Tu Q, Zhang Z, Chen M, Mwangi J, Li Y, Jin Y, Zhao X, Lai R |
Abstract: |
Pancreatic cancer remains one of the deadliest human cancers despite current advances in conventional therapeutics including surgery and adjuvant therapies. Here, we showed that LZ1, a peptide derived from a snake venom cathelicidin, significantly inhibited growth of pancreaticcancer cells by inducing autophagy-dependent cell death both in vitro and in vivo. The LZ1-induced cell death was blocked by pharmacological or genetic inhibition of autophagy. In orthotopic model of pancreatic cancer, systemic administration of LZ1 (1-4?mg/kg) exhibited remarkable antitumor efficacy, significantly prolonged mice survival, and showed negligible adverse effects by comparison with gemcitabine (20?mg/kg). Mechanistic studies revealed that LZ1 acts through binding to nucleolin, whose expression on cell surface is frequently increased in pancreatic cancer cells. LZ1 binding triggers degradation of surface-expressed nucleolin. This leads to activation of 5'-AMP kinase which results in suppression of mTORC1 activity and induction of autophagic flux. These data suggest that LZ1, targetingnucleolin-AMPK-autophagy axis, is a promising lead for the development of therapeutic agents against pancreatic cancer
|
Contact the author: |
|
Page number: |
|
Issue: |
|
Subject: |
|
Authors units: |
|
PubYear: |
2018 |
Volume: |
|
Unit code: |
152453 |
Publication name: |
Oncogene |
The full text link: |
Download |
Full papers: |
Download |
Departmens of first author: |
|
Paper source: |
https://www.nature.com/articles/s41388-018-0556-x |
Paper type: |
|
Participation of the author: |
|
EMAIL: |
|
|